Literature DB >> 26324805

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation.

Antonella Caminati1, Fabiana Madotto2, Giancarlo Cesana3, Sara Conti3, Sergio Harari4.   

Abstract

Data on incidence, prevalence and mortality of idiopathic pulmonary fibrosis (IPF) are sparse and vary across studies. The true incidence and prevalence of the disease are unknown. In general, the overall prevalence and incidence reported in European and Asian countries are lower than those reported in American studies. In recent years, the epidemiological approach to IPF has been difficult for many reasons. First, the diagnostic criteria of the disease have changed over time. Secondly, the coding system used for IPF in administrative databases, the most common data source used to study this aspect of the disease, has been modified in the past few years. Finally, the study design, the methodology and the population selected in each of the studies are very different. All these aspects make comparisons among studies very difficult or impossible. In this review, we list the main issues that might arise when comparing different studies and that should be taken into consideration when describing the state of epidemiological knowledge concerning this pathology.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26324805     DOI: 10.1183/16000617.0040-2015

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  14 in total

1.  Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway.

Authors:  Lawei Yang; Ziying Lin; Yahong Wang; Chunyan Li; Wenya Xu; Qinglan Li; Weimin Yao; Zeqing Song; Gang Liu
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-28       Impact factor: 4.223

Review 2.  Idiopathic pulmonary fibrosis in East Asian.

Authors:  Changbo Sun; Yanbin Sun; Hui Shen; Chunlu Yang; Shun Xu
Journal:  Intractable Rare Dis Res       Date:  2017-05

3.  The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities.

Authors:  Antonella Caminati; Fabiana Madotto; Sara Conti; Giancarlo Cesana; Lorenzo Mantovani; Sergio Harari
Journal:  Intern Emerg Med       Date:  2021-02-14       Impact factor: 3.397

4.  Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study.

Authors:  Dragana M Jovanovic; Martina Šterclová; Nesrin Mogulkoc; Katarzyna Lewandowska; Veronika Müller; Marta Hájková; Michael Studnicka; Jasna Tekavec-Trkanjec; Simona Littnerová; Martina Vašáková
Journal:  Respir Res       Date:  2022-05-27

5.  Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.

Authors:  Sergio Harari; Michele Davì; Alice Biffi; Antonella Caminati; Alessandra Ghirardini; Valeria Lovato; Claudio Cricelli; Francesco Lapi
Journal:  Intern Emerg Med       Date:  2019-09-20       Impact factor: 3.397

6.  Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data.

Authors:  Fernando Pedraza-Serrano; Ana López de Andrés; Rodrigo Jiménez-García; Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; Gema Sánchez-Muñoz; Luis Puente-Maestu; Javier de Miguel-Díez
Journal:  BMJ Open       Date:  2017-02-13       Impact factor: 2.692

7.  Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.

Authors:  Sarah Rank Rønnow; Rand Qais Dabbagh; Federica Genovese; Carmel B Nanthakumar; Vikki J Barrett; Robert B Good; Sarah Brockbank; Simon Cruwys; Henrik Jessen; Grith Lykke Sorensen; Morten Asser Karsdal; Diana Julie Leeming; Jannie Marie Bülow Sand
Journal:  Respir Res       Date:  2020-05-07

8.  Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.

Authors:  Sergio Harari; Fabiana Madotto; Antonella Caminati; Sara Conti; Giancarlo Cesana
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

Review 9.  Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.

Authors:  Yutaro Nakamura; Takafumi Suda
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-09-06

Review 10.  Role of pirfenidone in the management of pulmonary fibrosis.

Authors:  Keith C Meyer; Catherine A Decker
Journal:  Ther Clin Risk Manag       Date:  2017-04-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.